Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Planet Labs (PL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Planet Labs — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.09 (market cap $4.59B), while Planet Labs trades at $16.83 (market cap $6.25B). The key difference: Planet Labs is the larger of the two by market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Planet Labs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Planet Labs for 4 Days on average.
| DFTX | PL | |
|---|---|---|
Market Cap | $4.59B | $6.25B |
Volume | 2,103,937 | 19,125,340 |
Sector | Health | Industrials |
52-Week High | $48.45 | $51.40 |
52-Week Low | $10.68 | $11.16 |
Typical Hold Time | 0 Days | 4 Days |
Enterprise Value | $3.55B | $5.89B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Planet Labs
Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →
